investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Role of Inflammatory Neutrophils and their Unique MMP-9 in Tumor Progression
James P Quigley
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ghislain Opdenakker
University of Leuven
Leuven, Belgium
James P Quigley
Scripps Research Institute
San Diego, United States
Related projects
John V Frangioni
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
Prostate
Pathology
Stefan Ambs
The Molecular Profile of Prostate Tumors in African-American Men
Prostate
Pathology
Matthew L Freedman
Defining the epigenetic landscape in human prostate cancer
Prostate
Pathology
Mark A Rubin
Molecular Signatures of Lethal and Indolent Prostate Cancer
Prostate
Pathology
Anne E Cress
Human Prostate Cancer Metastasis and Laminin Binding Integrins
Prostate
Pathology
William Figg
Development of Drugs that Target Prostate Cancer
Prostate
Pathology
Robert E Reiter
UCLA SPORE in Prostate Cancer
Prostate
Pathology
Fredrick R Schumacher
Imputation-Based Approach to Identify Low Frequency Variants in Prostate Cancer
Prostate
Pathology
Ian M Thompson
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)
Prostate
Pathology
